A novel 5-HT 3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain

By Kiso T.   Ito H.   Miyata K.   Kamato T.   Naitoh Y.   Iwaoka K.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

Antiemetic effects of N-3389, a newly synthesized 5-HT 3 and 5-HT 4 receptor antagonist, in ferrets

By Minami M.   Endo T.   Tamakai H.   Ogawa T.   Hamaue N.   Hirafuji M.   Monma Y.   Yoshioka M.   Hagihara K.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite

Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT 3 receptor antagonist, in ferrets

By Yoshikawa T.   Yoshida N.   Oka M.  

European Journal of Pharmacology, Vol. 431, Iss. 3, 2001-11 ,pp. : 361-364

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of the novel, selective, 5-HT_2C receptor agonist WAY-163909 in rodents

By Rosenzweig-Lipson Sharon   Sabb Annmarie   Stack Gary   Mitchell Paul   Lucki Irwin   Malberg Jessica   Grauer Steve   Brennan Julie   Cryan John   Sukoff Rizzo Stacey   Dunlop John   Barrett James   Marquis Karen  

Psychopharmacology, Vol. 192, Iss. 2, 2007-06 ,pp. : 159-170

Springer Publishing Company

Access to resources Recommend Favorite